ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review.
JCO Precis Oncol
; 8: e2400154, 2024 Jun.
Article
en En
| MEDLINE
| ID: mdl-38885453
ABSTRACT
ALK-rearranged RCC refractory to several lines of treatment has a durable response when treated with alectinib.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Piperidinas
/
Carbazoles
/
Carcinoma de Células Renales
/
Reordenamiento Génico
/
Quinasa de Linfoma Anaplásico
/
Neoplasias Renales
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
JCO Precis Oncol
Año:
2024
Tipo del documento:
Article